𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer

✍ Scribed by Robert C. Millikan; Sue A. Ingles; Anh T. Diep; Shanyan Xue; Nianmin Zhou; Barbara D. Florentine; Robert S. Sparkes; Robert W. Haile


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
129 KB
Volume
25
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


We conducted linkage analysis of 64 multiple-case families with early-onset bilateral breast cancer using DNA markers on chromosome band 1p36. Evidence against tight linkage was obtained using a dominant model for transmission (summary LOD scores at recombination fraction Ο­ 0.000001 were -4.71 for D1S160 and -2.70 for D1S170). Similar results were obtained after excluding 20 families that were potentially attributable to BRCA1 or BRCA2. We also investigated loss of heterozygosity for a panel of markers on chromosome arm 1p using breast tumors from affected family members. The most common regions of allele loss were 1p36 (32% for D1S160, 35% for D1S243) and 1p32 (51% for MYCL). The frequency and location of 1p allele loss did not differ substantially from previous studies of sporadic breast cancer. We conclude that 1p36 probably does not contain a locus of susceptibility for a large proportion of breast cancer families, but a variety of loci on 1p may contribute to progression of familial and sporadic disease.


πŸ“œ SIMILAR VOLUMES


Loss of heterozygosity on chromosome arm
✍ Keltouma Driouch; FranΓ§oise Dorion-Bonnet; Marianne Briffod; Marie-HΓ©lΓ¨ne ChampΓ¨ πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

One of the main genetic abnormalities associated with breast carcinogenesis is the loss of genetic material from chromosome arm 16q. Different groups have identified two regions (16q22.1 and 16q24-ter) that are frequently deleted in primary tumors, suggesting the presence of tumor suppressor genes i

Loss of heterozygosity at loci from chro
✍ Florence Allione; FranΓ§ois Eisinger; Patricia Parc; Tetsuro Noguchi; Hagay Sobol πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 196 KB πŸ‘ 1 views

Forty-four breast carcinomas were studied for loss of heterozygosity (LOH) at 25 microsatellite markers distributed almost evenly along chromosome arm 22q. LOH at at least one marker were observed in 66% tumors, while 6 regions of consistent LOH were identified. The size of each region ranged betwee

Loss of heterozygosity studies indicate
✍ Catherine A. Thrash-Bingham; Hernando Salazar; Richard E. Greenberg; Kenneth D. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 387 KB πŸ‘ 1 views

We carried out a complete genome scan for loss of heterozygosity (LOH) in four renal oncocytomas by using highly polymorphic CA repeat microsatellite loci. Three of the four tumors exhibited LOH for chromosome arm I p, and the oncocytomas of both female patients lost Xq. Therefore, these chromosome

Loss of heterozygosity on chromosome 9 a
✍ FranΓ§oise Muzeau; Jean FranΓ§ois FlΓ©jou; Gilles Thomas; Richard Hamelin πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 131 KB πŸ‘ 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar